BIO 2024 | Schedule 1-on-1 Meetings with us!
May 20, 2024
Biocytogen’s antibody business development and licensing (BDL) team is excited to host 1-on-1 meetings at Bio International Convention 2024, taking place from June 3-6, 2024 in San Diego, CA! Schedule 1-on-1 Meetings Our Fully Human Library. Your Pipeline. Leveraging our proprietary RenMice® discovery platforms, Biocytogen has generated a vast antibody library consisting […]
GV Safety Assessment Platform (GVSAP) and Biocytogen Forge Strategic Collaboration to Accelerate Biopharmaceutical Innovation
Source: https://www.businesswireindia.com/gv-safety-assessment-platform-gvsap-and-biocytogen-forge-strategic-collaboration-to-accelerate-biopharmaceutical-innovation-90079.html Hyderabad, Telangana, India – May 17, 2024 – GV Safety Assessment Platform (GVSAP), a leading integrated R&D enabler offering comprehensive preclinical research solutions, proudly announces a groundbreaking partnership with Biocytogen, a leader in industry-leading technologies that propel drug discovery. This collaboration marks a significant advancement in biomedical research, aimed at bolstering the R&D […]
